Lot 99
Swedish (1941-2016)
Untitled (Papers)
Medium

lithograph

Dimensions

sheet: 25 x 35 inches

Signature

signed lower right, A.P.

Estimate: $100 - $200

Price Realized: $544
Includes buyer's premium

Have one like this?

Frame Information

frame dimensions: 39 1/4 x 28 1/4 x 1 3/4 inches, wood frame with glazing

Provenance

From the Collection of Memorial Sloan Kettering Cancer Center

Condition

overall good condition, not examined out of frame

Yrjö Edelmann

Swedish 1941-2016

Yrjö Edelmann made a significant contribution to the art world, particularly in the realm of hyper-realism and magic realism. Edelmann developed a unique painting technique that involved multiple layers of paint and varnish to create incredibly detailed and realistic images. Edelmann gained widespread recognition both in Finland and internationally for his artwork. Edelmann had a unique ability to transform ordinary objects into extraordinary works of art. His paintings often featured everyday items like candy, flowers, and glassware, but his attention to detail and use of vibrant colors imbued these subjects with a sense of wonder and beauty.

A selection from

Memorial Sloan Kettering Cancer Center

Image for Collection Memorial Sloan Kettering Cancer Center

Proceeds from this sale will directly benefit The Society of MSK, which was founded in 1946 by a group of forward-thinking women dedicated to enhancing the hospital environment and level of patient support that have always been the hallmarks of MSK. Today, the Society has evolved into a full partner of MSK as an internationally renowned organization involved in both policy and fundraising in support of research, patient care programs and education. 


Memorial Sloan Kettering Cancer Center is the world's oldest and largest private cancer center, providing comprehensive care to patients from all walks of life. Renowned for its cutting-edge research, innovative treatments, and compassionate approach to care, Memorial Sloan Kettering Cancer Center is dedicated to making progress against cancer and improving outcomes for patients worldwide.